Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane, Phase III Study.

NCT01503606 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01503606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01503606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane, Phase III Study.
Lead sponsor
Samsung Medical Center
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2021
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm premature rupture of membrane